OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies
Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105710-105710
Closed Access | Times Cited: 24
Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105710-105710
Closed Access | Times Cited: 24
Showing 24 citing articles:
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 40
Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 40
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies
Mahfam Moradi, Ali Mousavi, Zahra Emamgholipour, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115626-115626
Closed Access | Times Cited: 27
Mahfam Moradi, Ali Mousavi, Zahra Emamgholipour, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115626-115626
Closed Access | Times Cited: 27
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 13
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 13
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 16
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 16
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 4
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 4
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
[Cell@Al2O3(HEPiPY)]DCA: A Cellulose Supported Ionic Liquid Catalyst for Synthesis of 11 b,12‐dihydro‐6H,13Hbenzo[5,6][1,3]oxazino[3,4‐a]quinazoline‐6,13‐dione along with in silico assessments
Vikas B. Shinde, Pradeep M. Mhaldar, Mayuri Patil, et al.
ChemistrySelect (2024) Vol. 9, Iss. 4
Closed Access | Times Cited: 2
Vikas B. Shinde, Pradeep M. Mhaldar, Mayuri Patil, et al.
ChemistrySelect (2024) Vol. 9, Iss. 4
Closed Access | Times Cited: 2
Quinazoline derivatives and hybrids: recent structures with potent bioactivity
Ibrahim A. Bala, Abdullah M. Asiri, Reda M. El‐Shishtawy
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 2
Ibrahim A. Bala, Abdullah M. Asiri, Reda M. El‐Shishtawy
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 2
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access | Times Cited: 1
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access | Times Cited: 1
Bio-evaluation of the 2-nitrochalcones as potential anti-lung cancer agents, inducers of apoptosis and inhibitors of protein kinase (VEGFR-2)
Malose J. Mphahlele, Garland K. More, Marole M. Maluleka, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2380-2393
Open Access | Times Cited: 3
Malose J. Mphahlele, Garland K. More, Marole M. Maluleka, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2380-2393
Open Access | Times Cited: 3
Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies
Derya Osmani̇ye, Nurnehir BALTACİ, Berkant Kurban, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 2
Derya Osmani̇ye, Nurnehir BALTACİ, Berkant Kurban, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 2
Antibacterial evaluation of 2-(6-Chloro-2-p-tolylquinazolin-4-ylthio) acetonitrile against pathogenic bacterial isolates with special reference to biofilm formation inhibition and anti-adherence properties
Sultan Alasmari, Mohammed H. Makkawi, Irfan Ahmad, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103316-103316
Open Access
Sultan Alasmari, Mohammed H. Makkawi, Irfan Ahmad, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103316-103316
Open Access
Identification of novel PAD2 inhibitors using pharmacophore-based virtual screening, molecular docking, and MD simulation studies
Prakash Jha, Prerna Rajoria, Priya Poonia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Prakash Jha, Prerna Rajoria, Priya Poonia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access
EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS
Abdelsalam Ouf, Adel A. Marzouk, Montaser Shykhoon, et al.
Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 82-110
Open Access
Abdelsalam Ouf, Adel A. Marzouk, Montaser Shykhoon, et al.
Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 82-110
Open Access
